Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2022
Sensient Technologies reported a 10.7% increase in consolidated revenue for Q2 2022, reaching $371.7 million, compared to $335.8 million in Q2 2021. Operating income rose to $55.2 million from $35.8 million. Diluted earnings per share (EPS) also increased to 92 cents from 61 cents. Revenue was hindered by 3% foreign currency translation impact. The Flavors & Extracts segment had a 5.5% growth, while the Color Group increased 17.3%. Sensient's 2022 outlook remains positive, with anticipated EPS growth and high single-digit revenue growth in local currency.
- Consolidated revenue increased by 10.7% to $371.7 million.
- Operating income grew to $55.2 million, a rise of 54.6%.
- Diluted EPS rose to 92 cents, a 50.8% increase.
- Flavors & Extracts revenue increased by 5.5%, and Color Group revenue increased by 17.3%.
- 2022 outlook confirms high single-digit revenue growth in local currency.
- Foreign currency translation negatively impacted revenue by approximately 3%.
- Foreign currency translation decreased earnings per share by approximately 5%.
Double-Digit Growth in Reported and Adjusted Revenue
Sensient Operating at or Above its 2022 Guidance
The 2021 second quarter reported results included divestiture & other related costs and operational improvement plan costs, which in total decreased 2021 second quarter diluted earnings per share by
BUSINESS REVIEW
Reported | ||||||
Revenue | Quarter |
|
Year-to-Date |
|||
Flavors & Extracts |
|
|
- |
|||
Color |
|
|
|
|||
|
|
|
||||
Total Revenue |
|
|
|
|||
|
|
|
||||
Adjusted |
||||||
Local Currency (1) |
||||||
Revenue | Quarter |
|
Year-to-Date |
|||
Flavors & Extracts |
|
|
|
|||
Color |
|
|
|
|||
|
|
|
||||
Total Revenue |
|
|
|
|||
(1) Adjusted local currency percentage changes are described in more detail in the "Reconciliation of Non-GAAP Amounts" at the end of this release. |
Corporate & Other reported operating costs of
2022 OUTLOOK
The Company now expects 2022 revenue to grow at a high single digit rate in local currency compared to the Company’s 2021 adjusted revenue(2). The Company’s previous 2022 revenue guidance was for a mid-to-high single digit growth rate in local currency. The Company is reconfirming its expectation for 2022 adjusted EBITDA(2) and diluted earnings per share to grow at a high single- to double-digit rate in local currency compared to the Company’s 2021 adjusted EBITDA(2) and the Company’s 2021 adjusted diluted earnings per share(2) of
The Company now expects full year 2022 earnings per share reported on a
The Company’s guidance is based on current conditions and trends in the economy and the markets in which the Company operates and is subject to various risks and uncertainties as described below. The Company will continue to monitor the impacts of the ongoing COVID-19 pandemic and the conflict between
(2) See “Reconciliation of Non-GAAP Amounts” at the end of this release for more information.
USE OF NON-GAAP FINANCIAL MEASURES
The Company’s non-GAAP financial measures eliminate the impact of certain items, which, depending on the measure, include; currency movements, depreciation and amortization, non-cash share-based compensation, divestiture & other related costs, operational improvement plan costs and income, and the results of the divested operations. These measures are provided to enhance the overall understanding of the Company’s performance when viewed together with the GAAP results. Refer to “Reconciliation of Non-GAAP Amounts” at the end of this release.
CONFERENCE CALL
The Company will host a conference call to discuss its 2022 second quarter financial results at
A replay of the call will be available one hour after the end of the conference call through
This release contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws including under “2022 Outlook” above. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the impact and uncertainty created by the ongoing COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, the availability and cost of raw materials, energy, and other supplies, the availability and cost of labor, logistics, and transportation; the uncertain impacts of the ongoing conflict between
ABOUT
(In thousands, except percentages and per share amounts) | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
Consolidated Statements of Earnings | Three Months Ended |
Six Months Ended |
||||||||||||||||||
2022 |
2021 |
% Change |
2022 |
2021 |
|
% Change | ||||||||||||||
|
|
|||||||||||||||||||
Revenue | $ |
371,706 |
|
$ |
335,827 |
|
|
$ |
727,227 |
|
$ |
695,529 |
|
|
||||||
|
|
|||||||||||||||||||
Cost of products sold |
|
240,703 |
|
|
224,233 |
|
|
|
471,378 |
|
|
468,322 |
|
|
||||||
Selling and administrative expenses |
|
75,759 |
|
|
75,841 |
|
( |
|
147,816 |
|
|
144,557 |
|
|
||||||
|
|
|||||||||||||||||||
Operating income |
|
55,244 |
|
|
35,753 |
|
|
|
108,033 |
|
|
82,650 |
|
|
||||||
Interest expense |
|
3,083 |
|
|
3,322 |
|
|
|
6,076 |
|
|
6,755 |
|
|
||||||
|
|
|||||||||||||||||||
Earnings before income taxes |
|
52,161 |
|
|
32,431 |
|
|
|
101,957 |
|
|
75,895 |
|
|
||||||
Income taxes |
|
13,514 |
|
|
6,495 |
|
|
|
26,239 |
|
|
18,291 |
|
|
||||||
|
|
|||||||||||||||||||
Net earnings | $ |
38,647 |
|
$ |
25,936 |
|
|
$ |
75,718 |
|
$ |
57,604 |
|
|
||||||
|
|
|||||||||||||||||||
Earnings per share of common stock: |
|
|
||||||||||||||||||
Basic | $ |
0.92 |
|
$ |
0.62 |
|
|
$ |
1.81 |
|
$ |
1.37 |
|
|
||||||
|
|
|||||||||||||||||||
Diluted | $ |
0.92 |
|
$ |
0.61 |
|
|
$ |
1.80 |
|
$ |
1.36 |
|
|
||||||
|
|
|||||||||||||||||||
Average common shares outstanding: |
|
|
||||||||||||||||||
Basic |
|
41,893 |
|
|
42,135 |
|
|
|
41,879 |
|
|
42,199 |
|
|
||||||
|
|
|||||||||||||||||||
Diluted |
|
42,208 |
|
|
42,267 |
|
|
|
42,178 |
|
|
42,328 |
|
|
||||||
|
|
|||||||||||||||||||
|
|
|||||||||||||||||||
|
|
|||||||||||||||||||
Results by Segment | Three Months Ended |
Six Months Ended |
||||||||||||||||||
|
|
|||||||||||||||||||
Revenue |
2022 |
2021 |
% Change |
2022 |
2021 |
% Change | ||||||||||||||
|
|
|||||||||||||||||||
Flavors & Extracts | $ |
189,337 |
|
$ |
179,401 |
|
|
$ |
372,064 |
|
$ |
380,312 |
|
( |
||||||
Color |
|
156,268 |
|
|
133,207 |
|
|
|
304,706 |
|
|
268,927 |
|
|
||||||
|
37,328 |
|
|
32,317 |
|
|
|
73,793 |
|
|
66,157 |
|
|
|||||||
Intersegment elimination |
|
(11,227 |
) |
|
(9,098 |
) |
|
|
(23,336 |
) |
|
(19,867 |
) |
|
||||||
|
|
|||||||||||||||||||
Consolidated | $ |
371,706 |
|
$ |
335,827 |
|
|
$ |
727,227 |
|
$ |
695,529 |
|
|
||||||
|
|
|||||||||||||||||||
|
|
|||||||||||||||||||
Operating Income |
|
|
||||||||||||||||||
|
|
|||||||||||||||||||
Flavors & Extracts | $ |
30,013 |
|
$ |
24,536 |
|
|
$ |
57,592 |
|
$ |
51,554 |
|
|
||||||
Color |
|
31,178 |
|
|
25,615 |
|
|
|
61,835 |
|
|
52,209 |
|
|
||||||
|
7,721 |
|
|
5,793 |
|
|
|
15,925 |
|
|
12,545 |
|
|
|||||||
Corporate & Other |
|
(13,668 |
) |
|
(20,191 |
) |
|
|
(27,319 |
) |
|
(33,658 |
) |
|
||||||
|
|
|||||||||||||||||||
Consolidated | $ |
55,244 |
|
$ |
35,753 |
|
|
$ |
108,033 |
|
$ |
82,650 |
|
|
(In thousands) | ||||||||
(Unaudited) | ||||||||
Consolidated Condensed Balance Sheets |
|
|
||||||
2022 |
2021 |
|||||||
Cash and cash equivalents | $ |
25,271 |
|
$ |
25,740 |
|
||
Trade accounts receivable |
|
295,948 |
|
|
261,121 |
|
||
Inventories |
|
452,161 |
|
|
411,635 |
|
||
Prepaid expenses and other current assets |
|
48,146 |
|
|
42,657 |
|
||
Total Current Assets |
|
821,526 |
|
|
741,153 |
|
||
|
417,538 |
|
|
435,009 |
|
|||
Property, plant, and equipment (net) |
|
443,675 |
|
|
446,478 |
|
||
Other assets |
|
120,483 |
|
|
122,853 |
|
||
Total Assets | $ |
1,803,222 |
|
$ |
1,745,493 |
|
||
Trade accounts payable | $ |
140,776 |
|
$ |
125,519 |
|
||
Short-term borrowings |
|
26,624 |
|
|
8,539 |
|
||
Other current liabilities |
|
96,516 |
|
|
98,247 |
|
||
Total Current Liabilities |
|
263,916 |
|
|
232,305 |
|
||
Long-term debt |
|
498,715 |
|
|
503,006 |
|
||
Accrued employee and retiree benefits |
|
28,193 |
|
|
28,579 |
|
||
Other liabilities |
|
53,431 |
|
|
43,178 |
|
||
Shareholders' Equity |
|
958,967 |
|
|
938,425 |
|
||
Total Liabilities and Shareholders' Equity | $ |
1,803,222 |
$ |
1,745,493 |
(In thousands, except per share amounts) | ||||||||
(Unaudited) | ||||||||
Consolidated Statements of Cash Flows | ||||||||
Six Months Ended |
||||||||
2022 |
2021 |
|||||||
Cash flows from operating activities: | ||||||||
Net earnings | $ |
75,718 |
|
$ |
57,604 |
|
||
Adjustments to arrive at net cash provided by operating activities: | ||||||||
Depreciation and amortization |
|
26,180 |
|
|
25,817 |
|
||
Share-based compensation expense |
|
8,691 |
|
|
4,188 |
|
||
Net (gain) loss on assets |
|
(38 |
) |
|
206 |
|
||
Loss on divestitures and other charges |
|
- |
|
|
13,511 |
|
||
Deferred income taxes |
|
12,244 |
|
|
1,702 |
|
||
Changes in operating assets and liabilities: | ||||||||
Trade accounts receivable |
|
(41,592 |
) |
|
(26,902 |
) |
||
Inventories |
|
(51,768 |
) |
|
19,357 |
|
||
Prepaid expenses and other assets |
|
(25,919 |
) |
|
(15,573 |
) |
||
Trade accounts payable and other accrued expenses |
|
20,501 |
|
|
9,632 |
|
||
Accrued salaries, wages, and withholdings |
|
(4,188 |
) |
|
(3,944 |
) |
||
Income taxes |
|
2,765 |
|
|
1,953 |
|
||
Other liabilities |
|
199 |
|
|
1,710 |
|
||
Net cash provided by operating activities |
|
22,793 |
|
|
89,261 |
|
||
Cash flows from investing activities: | ||||||||
Acquisition of property, plant, and equipment |
|
(32,468 |
) |
|
(25,550 |
) |
||
Proceeds from sale of assets |
|
92 |
|
|
169 |
|
||
Proceeds from divestiture of businesses |
|
- |
|
|
36,255 |
|
||
Other investing activities |
|
1,571 |
|
|
(254 |
) |
||
Net cash (used in) provided by investing activities |
|
(30,805 |
) |
|
10,620 |
|
||
Cash flows from financing activities: | ||||||||
Proceeds from additional borrowings |
|
69,424 |
|
|
25,997 |
|
||
Debt payments |
|
(31,547 |
) |
|
(62,578 |
) |
||
Purchase of treasury stock |
|
- |
|
|
(22,507 |
) |
||
Dividends paid |
|
(34,446 |
) |
|
(33,027 |
) |
||
Other financing activities |
|
(2,056 |
) |
|
(582 |
) |
||
Net cash provided by (used in) financing activities |
|
1,375 |
|
|
(92,697 |
) |
||
Effect of exchange rate changes on cash and cash equivalents |
|
6,168 |
|
|
1,352 |
|
||
Net (decrease) increase in cash and cash equivalents |
|
(469 |
) |
|
8,536 |
|
||
Cash and cash equivalents at beginning of period |
|
25,740 |
|
|
24,770 |
|
||
Cash and cash equivalents at end of period | $ |
25,271 |
|
$ |
33,306 |
|
||
Supplemental Information | ||||||||
Six Months Ended |
2022 |
2021 |
||||||
Dividends paid per share | $ |
0.82 |
|
$ |
0.78 |
|
(In thousands, except percentages and per share amounts) | ||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||
Reconciliation of Non-GAAP Amounts | ||||||||||||||||||||
The Company's results for the three and six months ended |
||||||||||||||||||||
Three Months Ended |
|
Six Months Ended |
||||||||||||||||||
2022 |
|
2021 |
|
% Change |
|
2022 |
|
2021 |
|
% Change |
||||||||||
Revenue (GAAP) | $ |
371,706 |
|
$ |
335,827 |
|
|
$ |
727,227 |
|
$ |
695,529 |
|
|
||||||
Revenue of the divested product lines |
|
- |
|
|
(2,207 |
) |
|
|
- |
|
|
(27,777 |
) |
|||||||
Adjusted revenue | $ |
371,706 |
|
$ |
333,620 |
|
|
$ |
727,227 |
|
$ |
667,752 |
|
|
||||||
|
||||||||||||||||||||
Operating income (GAAP) | $ |
55,244 |
|
$ |
35,753 |
|
|
$ |
108,033 |
|
$ |
82,650 |
|
|
||||||
Divestiture & other related costs – Cost of products sold |
|
- |
|
|
3 |
|
|
|
- |
|
|
28 |
|
|||||||
Divestiture & other related costs – Selling and administrative expenses |
|
- |
|
|
11,685 |
|
|
|
- |
|
|
13,232 |
|
|||||||
Operating loss (income) of the divested product lines |
|
- |
|
|
459 |
|
|
|
- |
|
|
(2,468 |
) |
|||||||
Operational improvement plan - Selling and administrative expenses |
|
- |
|
|
(3,494 |
) |
|
|
- |
|
|
(2,493 |
) |
|||||||
Adjusted operating income | $ |
55,244 |
|
$ |
44,406 |
|
|
$ |
108,033 |
|
$ |
90,949 |
|
|
||||||
|
||||||||||||||||||||
Net earnings (GAAP) | $ |
38,647 |
|
$ |
25,936 |
|
|
$ |
75,718 |
|
$ |
57,604 |
|
|
||||||
Divestiture & other related costs, before tax |
|
- |
|
|
11,688 |
|
|
|
- |
|
|
13,260 |
|
|||||||
Tax impact of divestiture & other related costs |
|
- |
|
|
(1,689 |
) |
|
|
- |
|
|
(896 |
) |
|||||||
Net loss (earnings) of the divested product lines, before tax |
|
- |
|
|
459 |
|
|
|
- |
|
|
(2,468 |
) |
|||||||
Tax impact of the divested product lines |
|
- |
|
|
(115 |
) |
|
|
- |
|
|
608 |
|
|||||||
Operational improvement plan income, before tax |
|
- |
|
|
(3,494 |
) |
|
|
- |
|
|
(2,493 |
) |
|||||||
Tax impact of operational improvement plan |
|
- |
|
|
455 |
|
|
|
- |
|
|
159 |
|
|||||||
Adjusted net earnings | $ |
38,647 |
|
$ |
33,240 |
|
|
$ |
75,718 |
|
$ |
65,774 |
|
|
||||||
|
||||||||||||||||||||
Diluted earnings per share (GAAP) | $ |
0.92 |
|
$ |
0.61 |
|
|
$ |
1.80 |
|
$ |
1.36 |
|
|
||||||
Divestiture & other related costs, net of tax |
|
- |
|
|
0.24 |
|
|
|
- |
|
|
0.29 |
|
|||||||
Results of operations of the divested product lines, net of tax |
|
- |
|
|
0.01 |
|
|
|
- |
|
|
(0.04 |
) |
|||||||
Operational improvement plan income, net of tax |
|
- |
|
|
(0.07 |
) |
|
|
- |
|
|
(0.06 |
) |
|||||||
Adjusted diluted earnings per share | $ |
0.92 |
$ |
0.79 |
|
|
$ |
1.80 |
$ |
1.55 |
|
|
||||||||
Note: Earnings per share calculations may not foot due to rounding differences. |
(In thousands) | ||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||
Reconciliation of Non-GAAP Amounts - Continued | ||||||||||||||||||||||||
Results by Segment |
Three Months Ended |
|||||||||||||||||||||||
Revenue |
2022 |
|
Adjustments (1) |
|
Adjusted
|
|
2021 |
|
Adjustments (1) |
|
Adjusted
|
|||||||||||||
Flavors & Extracts | $ |
189,337 |
|
$ |
- |
|
$ |
189,337 |
|
$ |
179,401 |
|
$ |
(1,415 |
) |
$ |
177,986 |
|
||||||
Color |
|
156,268 |
|
|
- |
|
|
156,268 |
|
|
133,207 |
|
|
(792 |
) |
|
132,415 |
|
||||||
|
37,328 |
|
|
- |
|
|
37,328 |
|
|
32,317 |
|
|
- |
|
|
32,317 |
|
|||||||
Intersegment elimination |
|
(11,227 |
) |
|
- |
|
|
(11,227 |
) |
|
(9,098 |
) |
|
- |
|
|
(9,098 |
) |
||||||
Consolidated | $ |
371,706 |
|
$ |
- |
|
$ |
371,706 |
|
$ |
335,827 |
|
$ |
(2,207 |
) |
$ |
333,620 |
|
||||||
Operating Income | ||||||||||||||||||||||||
Flavors & Extracts | $ |
30,013 |
|
$ |
- |
|
$ |
30,013 |
|
$ |
24,536 |
|
$ |
(45 |
) |
$ |
24,491 |
|
||||||
Color |
|
31,178 |
|
|
- |
|
|
31,178 |
|
|
25,615 |
|
|
504 |
|
|
26,119 |
|
||||||
|
7,721 |
|
|
- |
|
|
7,721 |
|
|
5,793 |
|
|
- |
|
|
5,793 |
|
|||||||
Corporate & Other |
|
(13,668 |
) |
|
- |
|
|
(13,668 |
) |
|
(20,191 |
) |
|
8,194 |
|
|
(11,997 |
) |
||||||
Consolidated | $ |
55,244 |
|
$ |
- |
|
$ |
55,244 |
|
$ |
35,753 |
|
$ |
8,653 |
|
$ |
44,406 |
|
||||||
Results by Segment |
Six Months Ended |
|||||||||||||||||||||||
Revenue |
2022 |
|
Adjustments (1) |
|
Adjusted
|
|
2021 |
|
Adjustments (1) |
|
Adjusted
|
|||||||||||||
Flavors & Extracts | $ |
372,064 |
|
$ |
- |
|
$ |
372,064 |
|
$ |
380,312 |
|
$ |
(26,304 |
) |
$ |
354,008 |
|
||||||
Color |
|
304,706 |
|
|
- |
|
|
304,706 |
|
|
268,927 |
|
|
(1,328 |
) |
|
267,599 |
|
||||||
|
73,793 |
|
|
- |
|
|
73,793 |
|
|
66,157 |
|
|
(295 |
) |
|
65,862 |
|
|||||||
Intersegment elimination |
|
(23,336 |
) |
|
- |
|
|
(23,336 |
) |
|
(19,867 |
) |
|
150 |
|
|
(19,717 |
) |
||||||
Consolidated | $ |
727,227 |
|
$ |
- |
|
$ |
727,227 |
|
$ |
695,529 |
|
$ |
(27,777 |
) |
$ |
667,752 |
|
||||||
Operating Income | ||||||||||||||||||||||||
Flavors & Extracts | $ |
57,592 |
|
$ |
- |
|
$ |
57,592 |
|
$ |
51,554 |
|
$ |
(2,925 |
) |
$ |
48,629 |
|
||||||
Color |
|
61,835 |
|
|
- |
|
|
61,835 |
|
|
52,209 |
|
|
544 |
|
|
52,753 |
|
||||||
|
15,925 |
|
|
- |
|
|
15,925 |
|
|
12,545 |
|
|
(87 |
) |
|
12,458 |
|
|||||||
Corporate & Other |
|
(27,319 |
) |
|
- |
|
|
(27,319 |
) |
|
(33,658 |
) |
|
10,767 |
|
|
(22,891 |
) |
||||||
Consolidated | $ |
108,033 |
|
$ |
- |
$ |
108,033 |
|
$ |
82,650 |
|
$ |
8,299 |
|
$ |
90,949 |
|
(1) For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, adjustments consist of the results of the divested product lines, divestiture & other related costs, and 2021 operational improvement plan costs and income. |
(In thousands, except percentages) | ||||||||
(Unaudited) | ||||||||
Reconciliation of Non-GAAP Amounts - Continued | ||||||||
The following tables summarize the percentage change in the 2022 results compared to the 2021 results for the corresponding periods. | ||||||||
Three Months Ended |
||||||||
Revenue | Total | Foreign Exchange Rates |
Adjustments (2) | Adjusted Local Currency |
||||
Flavors & Extracts |
|
|
( |
|
( |
|
|
|
Color |
|
|
( |
|
( |
|
|
|
|
|
( |
|
|
|
|
||
Total Revenue |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|
||
Operating Income |
|
|
|
|
|
|
|
|
Flavors & Extracts |
|
|
( |
|
( |
|
|
|
Color |
|
|
( |
|
|
|
|
|
|
|
( |
|
|
|
|
||
Corporate & Other |
( |
|
|
|
( |
|
|
|
Total Operating Income |
|
|
( |
|
|
|
|
|
Diluted Earnings Per Share |
|
|
( |
|
|
|
|
|
Adjusted EBITDA |
|
|
( |
|
N/A |
|
|
|
Six Months Ended |
||||||||
Revenue | Total | Foreign Exchange Rates |
Adjustments (2) | Adjusted Local Currency |
||||
Flavors & Extracts |
( |
|
( |
|
( |
|
|
|
Color |
|
|
( |
|
( |
|
|
|
|
|
( |
|
( |
|
|
||
Total Revenue |
|
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|
||
Operating Income |
|
|
|
|
|
|
|
|
Flavors & Extracts |
|
|
( |
|
( |
|
|
|
Color |
|
|
( |
|
|
|
|
|
|
|
( |
|
( |
|
|
||
Corporate & Other |
( |
|
|
|
( |
|
|
|
Total Operating Income |
|
|
( |
|
|
|
|
|
Diluted Earnings Per Share |
|
|
( |
|
|
|
|
|
Adjusted EBITDA |
|
|
( |
|
N/A |
|
|
(2) For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, Diluted Earnings per Share, and Adjusted EBITDA, adjustments consist of the results of the divested product lines, divestiture & other related costs, and 2021 operational improvement plan costs and income. |
The following table summarizes the reconciliation between Operating Income (GAAP) and Adjusted EBITDA for the three and six months ended |
Three Months Ended |
|
Six Months Ended |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2022 |
|
2021 |
|
% Change |
|
2022 |
|
2021 |
|
% Change |
||||||||||
Operating income (GAAP) | $ |
55,244 |
|
$ |
35,753 |
|
|
$ |
108,033 |
|
$ |
82,650 |
|
|
||||||
Depreciation and amortization |
|
13,124 |
|
|
13,018 |
|
|
26,180 |
|
|
25,817 |
|
||||||||
Depreciation and amortization, divested product lines |
|
- |
|
|
(48 |
) |
|
- |
|
|
(97 |
) |
||||||||
Share-based compensation expense |
|
4,528 |
|
|
2,075 |
|
|
8,691 |
|
|
4,188 |
|
||||||||
Divestiture & other related costs, before tax |
|
- |
|
|
11,688 |
|
|
- |
|
|
13,260 |
|
||||||||
Results of operations of the divested product lines, before tax |
|
- |
|
|
459 |
|
|
- |
|
|
(2,468 |
) |
||||||||
Operational improvement plan costs (income), before tax |
|
- |
|
|
(3,494 |
) |
|
- |
|
|
(2,493 |
) |
||||||||
Adjusted EBITDA | $ |
72,896 |
$ |
59,451 |
|
|
$ |
142,904 |
$ |
120,857 |
|
|
The following table summarizes the reconciliation between Net cash provided by operating activities (GAAP) and Free Cash Flow for the three and six months ended |
Three Months Ended |
Six Months Ended |
|||||||||||||||||||||
2022 |
|
2021 |
|
% Change |
|
2022 |
|
2021 |
|
% Change |
||||||||||||
Net cash provided by operating activities (GAAP) | $ |
23,685 |
|
$ |
60,297 |
|
(60.7 |
%) |
$ |
22,793 |
|
$ |
89,261 |
|
(74.5 |
%) |
||||||
Capital expenditures |
|
(19,732 |
) |
|
(11,306 |
) |
|
(32,468 |
) |
|
(25,550 |
) |
||||||||||
Free Cash Flow | $ |
3,953 |
|
$ |
48,991 |
|
(91.9 |
%) |
$ |
(9,675 |
) |
$ |
63,711 |
|
(115.2 |
%) |
We have included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable period-over-period performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this release and our |
Category: Earnings
View source version on businesswire.com: https://www.businesswire.com/news/home/20220721005644/en/
(414) 347-3706
Source:
FAQ
What were Sensient Technologies' Q2 2022 revenue figures for SXT?
How did Sensient's earnings per share change in Q2 2022?
What is Sensient's outlook for 2022?
What impact did foreign currency have on Sensient's Q2 2022 results?